BioCentury
ARTICLE | Company News

MiMedx delays earnings filing due to internal audit

February 23, 2018 8:21 PM UTC

Regenerative medicines company MiMedx Group Inc. (NASDAQ:MDXG) said it will delay the release of its fourth quarter and fiscal-year 2017 financial results as the company conducts an internal investigation into “current and prior-period matters relating to allegations regarding certain sales and distribution practices.”

MiMedx said it will delay its 10-K SEC filing and that financial results will not be released until the internal audit has been completed...

BCIQ Company Profiles

MiMedx Group Inc.